Lateral flow assays (LFAs) are paper-based point-of-care (POC) diagnostic tools that are
widely used because of their low cost, ease of use, and rapid format. Unfortunately …

Lateral flow assays (LFAs) are rapid, inexpensive, easy-to-manufacture and-use tests widely
employed in medical and environmental applications, particularly in low resource settings …

The development of reliable and robust diagnostic tests is one of the most efficient methods
to limit the spread of coronavirus disease 2019 (COVID-19), which is caused by the severe …

Nanozymes show great promise in enhancing disease biomarker sensing by leveraging
their physicochemical properties and enzymatic activities. These qualities facilitate signal …

Lateral flow immunoassay (LFIA) is widely used as a rapid point-of-care testing (POCT)
technique in food safety, veterinary and clinical detection on account of the accessible, fast …

Sepsis is one of the leading causes of death worldwide with high mortality rates and a
pathological complexity hindering early and accurate diagnosis. Today, laboratory culture …

Rapid diagnostics of adventitious agents in biopharmaceutical/cell manufacturing release
testing and the fight against viral infection have become critical. Quantitative real-time PCR …

Appropriate documentary standards and reference materials are crucial building blocks for
the development of innovative products. In order to support the emerging sector of …

An epidemic caused by the severe acute respiratory syndrome coronavirus (SARS-CoV-2)
spread globally in just a few months. To prevent the further spread of the virus, millions of …

Rapid and accurate diagnosis of sepsis remains clinically challenging. The lack of specific
biomarkers that can differentiate sepsis from non-infectious systemic inflammatory diseases …